| G Steven Bova – PELICAN Personalized Cancer Medicine |
| 2020-2025 |
[pmid-refs key=”Bova GS AND 2025%5Bdp%5D” limit=100]
[pmid-refs key=”Bova GS AND 2024%5Bdp%5D” limit=100]
[pmid-refs key=”Bova GS AND 2023%5Bdp%5D” limit=100]
[pmid-refs key=”Bova GS AND 2022%5Bdp%5D” limit=100]
[pmid-refs key=”Bova GS AND 2021%5Bdp%5D” limit=100]
[pmid-refs key=”Bova GS AND 2020%5Bdp%5D” limit=100]
[pmid-refs key=”Bova GS AND 2018%5Bdp%5D” limit=100]
| Jorma Isola – Cancer biology |
| 2021-2025 |
[pmid-refs key=”Isola Jorma AND 2025%5Bdp%5D” limit=100]
[pmid-refs key=”Isola Jorma AND 2024%5Bdp%5D” limit=100]
[pmid-refs key=”Isola Jorma AND 2023%5Bdp%5D” limit=100]
[pmid-refs key=”Isola Jorma AND 2022%5Bdp%5D” limit=100]
[pmid-refs key=”Isola Jorma AND 2021%5Bdp%5D” limit=100]
| Pirkko Kellokumpu-Lehtinen – Radiotherapy and Oncology |
| 2018-2025 |
[pmid-refs key=”Kellokumpu-Lehtinen P AND 2025%5Bdp%5D” limit=100]
[pmid-refs key=”Kellokumpu-Lehtinen P AND 2024%5Bdp%5D” limit=100]
[pmid-refs key=”Kellokumpu-Lehtinen P AND 2023%5Bdp%5D” limit=100]
[pmid-refs key=”Kellokumpu-Lehtinen P AND 2022%5Bdp%5D” limit=100]
[pmid-refs key=”Kellokumpu-Lehtinen P AND 2021%5Bdp%5D” limit=100]
[pmid-refs key=”Kellokumpu-Lehtinen P AND 2020%5Bdp%5D” limit=100]
[pmid-refs key=”Kellokumpu-Lehtinen P AND 2019%5Bdp%5D” limit=100]
[pmid-refs key=”Kellokumpu-Lehtinen P AND 2018%5Bdp%5D” limit=100]
| Olli Lohi – Hematology and oncology |
| 2020-2025 |
[pmid-refs key=”Lohi O AND 2025%5Bdp%5D” limit=100]
[pmid-refs key=”Lohi O AND 2024%5Bdp%5D” limit=100]
[pmid-refs key=”Lohi O AND 2023%5Bdp%5D” limit=100]
[pmid-refs key=”Lohi O AND 2022%5Bdp%5D” limit=100]
[pmid-refs key=”Lohi O AND 2021%5Bdp%5D” limit=100]
[pmid-refs key=”Lohi O AND 2020%5Bdp%5D” limit=100]
[pmid-refs key=”Lohi O AND 2019%5Bdp%5D” limit=100]
[pmid-refs key=”Lohi O AND 2018%5Bdp%5D” limit=100]
| Johanna Mäenpää – Gynaecological oncology |
| 2020-2025 |
[pmid-refs key=”Maenpaa J AND 2025%5Bdp%5D” limit=100]
[pmid-refs key=”Maenpaa J AND 2024%5Bdp%5D” limit=100]
[pmid-refs key=”Maenpaa J AND 2023%5Bdp%5D” limit=100]
[pmid-refs key=”Maenpaa J AND 2022%5Bdp%5D” limit=100]
[pmid-refs key=”Maenpaa J AND 2021%5Bdp%5D” limit=100]
[pmid-refs key=”Maenpaa J AND 2020%5Bdp%5D” limit=100]
[pmid-refs key=”Maenpaa J AND 2019%5Bdp%5D” limit=100]
[pmid-refs key=”Maenpaa J AND 2018%5Bdp%5D” limit=100]
| Daniela Ungureanu – Cancer Signalling |
| 2020-2024 |
[pmid-refs key=”Ungureanu Daniela AND 2024%5Bdp%5D” limit=100]
[pmid-refs key=”Ungureanu Daniela AND 2023%5Bdp%5D” limit=100]
[pmid-refs key=”Ungureanu Daniela AND 2022%5Bdp%5D” limit=100]
[pmid-refs key=”Ungureanu Daniela AND 2021%5Bdp%5D” limit=100]
[pmid-refs key=”Ungureanu Daniela AND 2020%5Bdp%5D” limit=100]
[pmid-refs key=”Ungureanu Daniela AND 2019%5Bdp%5D” limit=100]
[pmid-refs key=”Ungureanu Daniela AND 2018%5Bdp%5D” limit=100]
| Tapio Visakorpi – Molecular Biology of Prostate Cancer |
| 2020-2025 |
[pmid-refs key=”Visakorpi T AND 2025%5Bdp%5D” limit=100]
[pmid-refs key=”Visakorpi T AND 2024%5Bdp%5D” limit=100]
[pmid-refs key=”Visakorpi T AND 2023%5Bdp%5D” limit=100]
[pmid-refs key=”Visakorpi T OR Tammela TLJ AND 2022%5Bdp%5D” limit=100]
[pmid-refs key=”Visakorpi T OR Tammela TLJ AND 2021%5Bdp%5D” limit=100]
[pmid-refs key=”Visakorpi T OR Tammela TLJ AND 2020%5Bdp%5D” limit=100]
[pmid-refs key=”Visakorpi T OR Tammela TLJ AND 2019%5Bdp%5D” limit=100]
[pmid-refs key=”Visakorpi T OR Tammela TLJ AND 2018%5Bdp%5D” limit=100]